Abstract: A temperature sensor includes a detector and a first mold-resin body. The detector includes: a temperature sensing element which is disposed at a first end part of the detector, a terminal which is disposed at a second end part of the detector, and a lead wire for coupling the temperature sensing element to the terminal. The first mold-resin body covers the temperature sensing element, a portion the terminal, and the lead wire. The temperature sensor further includes a second mold-resin body which covers an another portion of the terminal and the first mold-resin body; the another portion of the terminal is exposed from the first mold-resin body. Then, a gate mark is formed on a surface of the second mold-resin body; the surface faces a side of the first end part.

Abstract: A temperature sensor includes a detector and a first mold-resin body. The detector includes: a temperature sensing element which is disposed at a first end part of the detector, a terminal which is disposed at a second end part of the detector, and a lead wire for coupling the temperature sensing element to the terminal. The first mold-resin body covers the temperature sensing element, a portion the terminal, and the lead wire. The temperature sensor further includes a second mold-resin body which covers an another portion of the terminal and the first mold-resin body; the another portion of the terminal is exposed from the first mold-resin body. Then, a gate mark is formed on a surface of the second mold-resin body; the surface faces a side of the first end part.

Abstract: A honeycomb structure includes a ceramic block. A plurality of honeycomb fired bodies include first-shaped units, second-shaped units, and third-shaped units. The first-shaped units include peripheral first-shaped units. Each of the peripheral first-shaped units is disposed in such a manner as to have two sides. One side of the two sides faces one of adjacent sides of one third-shaped unit among the third-shaped units with an adhesive layer therebetween. Another side of the two sides faces one of adjacent sides of another third-shaped unit among the third-shaped units with the adhesive layer therebetween. The two sides of each of the peripheral first-shaped units or extensions of the two sides are each neither substantially parallel nor substantially perpendicular to an extension of a second side and an extension of a first side of each of the second-shaped units.

Abstract: A honeycomb structure includes a ceramic block including honeycomb fired bodies. The honeycomb fired bodies include an assembly including a plurality of substantially quadrangular-cross-section units which are combined with one another with an adhesive layer interposed between the plurality of substantially quadrangular-cross-section units. A peripheral face of the assembly of substantially quadrangular-cross-section units has a concave portion and a convex portion formed in a substantially step-shaped pattern. At least one substantially triangular-cross-section unit has an outer wall on a periphery portion of the at least one substantially triangular-cross-section unit. The at least one substantially triangular-cross-section unit is fit in the concave portion with the adhesive layer interposed between the at least one substantially triangular-cross-section unit and the concave portion. A sealing material layer is provided on a peripheral face of the ceramic block.

Abstract: The present invention relates to an agent for preventing and/or treating diabetic neuropathy comprising a 2-[(substituted-inden-7-yloxy)methyl]morpholine of the formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient. The invention is useful for providing an excellent agent for preventing and/or treating diabetic neuropathy, and particularly useful for providing an agent for preventing and/or treating diabetic motor neuropathy (such as muscle weakness disorder (such as muscle weakness disorder with inability to walk independently)), diabetic sensory neuropathy (such as paresthesia (such as vibration perception abnormality), allodynia, hypoesthesia (such as numbness of extremities or cold sensation), or pain), or diabetic autonomic neuropathy (such as stool abnormality (such as constipation or diarrhea), urination disorder, impotence, orthostatic hypotension, sudomotor dysfunction, abnormal heart rate variability, or delayed gastric emptying).

Abstract: A method for manufacturing a honeycomb structure includes molding a ceramic raw material to manufacture honeycomb molded bodies. The honeycomb molded bodies are fired to manufacture honeycomb fired bodies. End faces of at least two of the honeycomb fired bodies are joined interposing a joining material between the end faces to manufacture honeycomb joined bodies each having a length larger than a length of each honeycomb fired body. Side faces of the honeycomb joined bodies are bonded interposing an adhesive paste between the side faces to manufacture an aggregated body of the honeycomb joined bodies. The adhesive paste is dried and solidified to manufacture a honeycomb block including the aggregated body. The honeycomb block is separated at the joining material into at least two honeycomb blocks.

Abstract: A honeycomb structure includes a ceramic block including honeycomb fired bodies. The honeycomb fired bodies includes at least one first-shaped unit having a substantially quadrangular shape in a cross section perpendicular to the longitudinal direction. At least one second-shaped unit has a shape that includes at least a first side, a second side making a substantially right angle with the first side, and an inclined side facing the substantially right angle in the cross section. The at least one second-shaped unit is located in a peripheral portion of the ceramic block and is disposed with the second side adjacent to the at least one first-shaped unit. The second side forming a periphery of the at least one second-shaped unit is longer than a longest side of four sides forming a periphery of the at least one first-shaped unit in the cross section.

Abstract: A honeycomb structure includes a ceramic block including honeycomb fired bodies. The honeycomb fired bodies include an assembly including a plurality of substantially quadrangular-cross-section units which are combined with one another with an adhesive layer interposed between the plurality of substantially quadrangular-cross-section units. A peripheral face of the assembly of substantially quadrangular-cross-section units has a concave portion and a convex portion formed in a substantially step-shaped pattern. At least one substantially triangular-cross-section unit has an outer wall on a periphery portion of the at least one substantially triangular-cross-section unit. The at least one substantially triangular-cross-section unit is fit in the concave portion with the adhesive layer interposed between the at least one substantially triangular-cross-section unit and the concave portion. A sealing material layer is provided on a peripheral face of the ceramic block.

Abstract: A honeycomb structure includes a ceramic block. A plurality of honeycomb fired bodies include first-shaped units, second-shaped units, and third-shaped units. The first-shaped units include peripheral first-shaped units. Each of the peripheral first-shaped units is disposed in such a manner as to have two sides. One side of the two sides faces one of adjacent sides of one third-shaped unit among the third-shaped units with an adhesive layer therebetween. Another side of the two sides faces one of adjacent sides of another third-shaped unit among the third-shaped units with the adhesive layer therebetween. The two sides of each of the peripheral first-shaped units or extensions of the two sides are each neither substantially parallel nor substantially perpendicular to an extension of a second side and an extension of a first side of each of the second-shaped units.

Abstract: The present invention relates to a pharmaceutical composition for treating nociceptive pain, containing a morpholine derivative or a pharmaceutically acceptable salt thereof, as an active ingredient. The present invention is useful in providing an excellent pharmaceutical composition for treating nociceptive pain. In addition, the present invention is particularly useful in providing a pharmaceutical composition for treating pain accompanying a disease selected from the group consisting of rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, spondylosis deformans, gouty arthritis, juvenile arthritis, scapulohumeral periarthritis, and cervical syndrome, lumbago, lumbago accompanying spondylosis deformans, menalgia, pain and tumentia after inflammation, operation or injury, pain after odontectomy, and cancer pain. In addition, the present invention is particularly useful for alleviating pain in a damaged cartilage region, and is particularly useful for osteoarthritis in which NSAIDs are not effective.

Abstract: A method for manufacturing a honeycomb structure includes molding a ceramic raw material to manufacture honeycomb molded bodies. The honeycomb molded bodies are fired to manufacture honeycomb fired bodies. End faces of at least two of the honeycomb fired bodies are joined interposing a joining material between the end faces to manufacture honeycomb joined bodies each having a length larger than a length of each honeycomb fired body. Side faces of the honeycomb joined bodies are bonded interposing an adhesive paste between the side faces to manufacture an aggregated body of the honeycomb joined bodies. The adhesive paste is dried and solidified to manufacture a honeycomb block including the aggregated body. The honeycomb block is separated at the joining material into at least two honeycomb blocks.

Abstract: A robot apparatus capable of offering significantly improved safety and a control method thereof by detecting a safety level status and a safety level of the safety level status and then, in response, taking prescribed countermeasures. In addition, in a movable robot apparatus and its control method, a safety level status detecting means for detecting a safety level status and a control means for performing a control process so as to implement prescribed countermeasures depending on the position of the safety level status detected by the safety level status detecting means are provided. Further, in a robot apparatus and its control method, a safety level involving an object and movable parts is detected when the object is detected, and the movable parts are moved so as to mitigate or avoid the danger based on the detected safety level and a determined action.

Abstract: The present invention relates to an agent for preventing and/or treating diabetic neuropathy comprising a 2-[(substituted-inden-7-yloxy)methyl]morpholine of the formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient. The invention is useful for providing an excellent agent for preventing and/or treating diabetic neuropathy, and particularly useful for providing an agent for preventing and/or treating diabetic motor neuropathy (such as muscle weakness disorder (such as muscle weakness disorder with inability to walk independently)), diabetic sensory neuropathy (such as paresthesia (such as vibration perception abnormality), allodynia, hypoesthesia (such as numbness of extremities or cold sensation), or pain), or diabetic autonomic neuropathy (such as stool abnormality (such as constipation or diarrhea), urination disorder, impotence, orthostatic hypotension, sudomotor dysfunction, abnormal heart rate variability, or delayed gastric emptying).

Abstract: The present invention relates to an agent for preventing and/or treating neuropathic pain comprising a 2-[(substituted-inden-7-yloxy)methyl]morpholine of the formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient. The invention is useful for providing an excellent agent for preventing and/or treating neuropathic pain, and particularly useful for providing an agent for preventing and/or treating allodynia, hyperalgesia, hyperesthesia, spontaneous pain, cancer pain, trigeminal neuralgia, phantom limb pain, postherpetic neuralgia, fibromyalgia, low back/leg pain, thalamic pain, entrapment (compressive) peripheral neuropathy, atypical facial pain, pain accompanying spinal cord injury, pain accompanying multiple sclerosis, pain accompanying chemotherapy-induced neuropathy, cancer pain on which an analgesic effect of a narcotic analgesic such as morphine is insufficient, pain accompanying diabetic neuropathy, and the like.

Abstract: The present inventors have carried out intensive screening of a new type compound which inhibits the P2X2/3,3 receptor and found as a result that minodronic acid as a bisphosphonate having bone resorption inhibitory action shows excellent P2X2/3,3 receptor inhibitory action and can be used as a preventive or therapeutic agent for various pains, thus accomplishing the invention. That is, the invention relates to a P2X2/3,3 receptor inhibitor, particularly an analgesic, which comprises minodronic acid or a salt thereof as the active ingredient. Since the “P2X2/3 and/or P2X3 receptor inhibitor” of the invention inhibits the function of P2X2/3,3 receptor known as a molecule which is concerned in various pains consisting of nociceptive pain, inflammatory pain and neurogenic pain, it is useful for the prevention or treatment of various pains in which the P2X2/3,3 receptor is concerned in the pain transduction.

Abstract: A robot apparatus capable of offering significantly improved safety and a control method thereof. In a movable robot apparatus and its control method, a safety level status is detected and the safety level of the detected safety level status is detected as well. Then a control process is performed so as to make the robot apparatus take prescribed countermeasures according to the detected safety level status and the safety level of the safety level status. In addition, in a movable robot apparatus and its control method, a safety level status detecting means for detecting a safety level status and a control means for performing a control process so as to implement prescribed countermeasures depending on the position of the safety level status detected by the safety level status detecting means are provided.

Abstract: A crawler carrier capable of smoothly operating a driving force source even at a slant. The driving force source is arranged between a dump body and a cab and laid in a lateral direction and at the same time the driving force source and a heat exchanger are arranged in series in a lateral direction. With such an arrangement as above, the driving force source can be arranged at an upper structure frame under a state in which it becomes substantially horizontal without interfering with the dump body. Even when the crawler carrier performs work at a slant the engine can always be lubricated with lubricant oil and the driving force source can be operated smoothly.

Abstract: A tired roller, which permits widening the field of view on both the left and right sides of an operator's section and is convenient for steering. In a tired roller with an operator's section arranged close to a right-hand side wall of a tired roller main body 11 and with an ingress-egress step 18 arranged on the tired roller main body 11, a space 20 for the arrangement of the ingress-egress step 18 is formed on the tired roller main body 11 at a position between a left-hand side wall and the operator's section. In the arrangement space 20, the ingress-egress step 18 which is provided with plural treads 21,22,23 is arranged extending aslant from the operator's section toward a lower part of the left-hand side wall, so that an operator 9 can look down at a road surface on the left side from the operator's section through a space above the treads 21,22,23.

Abstract: There is provided a crawler carrier capable of smoothly operating the driving force source even at a slant ground or the like. The driving force source is arranged between the dump body and the cab and laid in a lateral direction and at the same time the driving force source and the heat exchanger are arranged in series in a lateral direction. With such an arrangement as above, the driving force source can be arranged at the upper structure frame under a state in which it becomes substantially horizontal without being interfered with the dump body. With such an arrangement as above, even in the case that the crawler carrier performs a work at the slant ground such as a mountain area having a high gradient, the engine can always be lubricated with lubricant oil and the driving force source can be operated smoothly.

Abstract: The present invention relates to a container for holding high purity isopropyl alcohol (IPA) used in the electronic industry, which extremely dislike the inclusion of metal impurities. The container made of metal for holding high purity IPA, wherein at least the inside surface layer of the container is composed of nickel.